Uronephrological Complications Risk Factors in Spinal Dysraphism
ConditionSpinal Dysraphism
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris
About this trial
Spinal dysraphism consist of congenital malformations resulting of abnormalities in the formation of neural tube and/or surrounding structures during embryogenesis. The aim of this study is to assess if there are specific clinical and paraclinical patterns of pelvic (urinary, bowel, sexual) disorders depending on the dysraphism's type and level of injury.
This description will help to determine a prognosis on symptoms and the risk of complication depending on the dysraphism's type and level of injury. It will provide targeted evaluation and cares: identifying patients who will be at risk of complications and needing acute monitoring or preventing cares on the symptoms' onset.
Pelvic disorders have an important impact on morbi-mortality (urinary dysfunction is the first cause of mortality in adults by renal failure or infection) and also on patients' quality of life.
Eligibility criteria
Qualifiers
men and women over 18 years old with spinal dysraphism,
urinary and/or bowel and/or sexual dysfunction,
evaluated in a one day consultation in a neuro-urology department.
Informed consent is required from the patient or his tutor/curator if he is under legal protection
Disqualifiers
language barrier with non-understanding of French language,
other neurologic pathologies except syringomyelia, Chiari malformation or hydrocephalus who are often associated to spinal dysraphism.
Trial design
Treatments tested in this trial
- Individualisation of uronephrological complications risk factors
Treatment groups
200 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov